FDA cleared the Evident Vascular Guidance System from Evident Vascular, Inc. on Oct 28, 2026 under K261648, a traditional 510(k). The device falls under product code IYO, System, Imaging, Pulsed Echo, Ultrasonic, regulated at 21 CFR 892.1560 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on May 18, 2026. The decision came 163 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Evident Vascular, Inc. in the last 12 months of the tracker.
Questions & Answers
What did FDA clear under K261648?
K261648 is the FDA 510(k) for Evident Vascular Guidance System, submitted by Evident Vascular, Inc.. FDA's decision date was Oct 28, 2026, under product code IYO (System, Imaging, Pulsed Echo, Ultrasonic).
Who makes the Evident Vascular Guidance System?
Evident Vascular, Inc., based in San Jose, CA, is the applicant of record for K261648. The company is listed in the MedDevice Startups directory.
How long did the K261648 review take?
FDA received the submission on May 18, 2026 and issued its decision on Oct 28, 2026, 163 days later.